Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells-Reference-Cited by-同舟云学术

Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells

Published:2006-08 Issue:2 Volume:14 Page:164-174
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Bauerschmitz Gerd J.,Guse Kilian,Kanerva Anna,Menzel Artur,Herrmann Isabell,Desmond Renee A.,Yamamoto Masato,Nettelbeck Dirk M.,Hakkarainen Tanja,Dall Peter,Curiel David T.,Hemminki Akseli

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference36 articles.

1. Cancer statistics;Jemal;CA Cancer J. Clin.,2005

2. Adenoviral gene therapy for cancer: from vectors to targeted and replication competent agents;Bauerschmitz;Int. J. Oncol.,2002

3. Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses;Kanerva;Mol. Ther.,2002

4. Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells;Kanerva;Clin. Cancer Res.,2002

5. Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus;Kanerva;Mol. Ther.,2003

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving Horizons: Adenovirus Vectors’ Timeless Influence on Cancer, Gene Therapy and Vaccines;Viruses;2023-12-03

2. Adenovirus as a Vector and Oncolytic Virus;Current Issues in Molecular Biology;2023-06-02

3. Oncolytic viruses in immunotherapy;Cancer Immunology and Immunotherapy;2022

4. Oncolytic Adenovirus: Prospects for Cancer Immunotherapy;Frontiers in Microbiology;2021-07-21

5. Strategies to Develop Potent Oncolytic Viruses and Enhance Their Therapeutic Efficacy;JCO Precision Oncology;2021-04